Population Pharmacokinetic Model of Cabozantinib in Patients with Medullary Thyroid Carcinoma and Its Application to an Exposure-Response Analysis
2015; Adis, Springer Healthcare; Volume: 55; Issue: 1 Linguagem: Inglês
10.1007/s40262-015-0295-x
ISSN1179-1926
AutoresDale Miles, Nelson L. ‘Shasha’ Jumbe, Steven Lacy, Linh T. Nguyen,
Tópico(s)Statistical Methods in Clinical Trials
Referência(s)